IMMUNOCORE, LLC

FDA Regulatory Profile

IMMUNOCORE, LLC appears in FDA public data with 1 recall, 0 510(k) clearances, 1 FDA inspection, and 0 compliance actions on record. Its most recent recall (D-0614-2025, Class II) was initiated on June 10, 2025.

Summary

Total Recalls
1
510(k) Clearances
0
Inspections
1
Compliance Actions
0

Recent Recalls

NumberClassProductDate
D-0614-2025Class IIKIMMTRAK (tebentafusp-tebn) Injection, 100 mcg/0.5 mL, For intravenous Infusion After Dilution, SingJune 10, 2025